Quality assurance in the cell: Preventing defective protein blueprints
Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...
Taiwan News2d
Strategic update on the progress and development of Molecure's key clinical projects in 2024
Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...
Technology Networks3d
Structural Insights Into the Cell's Quality Control Machinery
They succeeded once they were able to isolate the splicing complexes of the fungus that were in the midst of quality control ...
C&EN3d
A bioluminescent probe to track RNA
Bioluminescent luciferase enzymes have historically been too dim to use as probes in living tissue. But recent advances have ...
Artificial cells can glow at room temperature in response to external target molecules
Cell-free systems, which can express an easily detectable protein with a DNA or mRNA template without constraints of living ...
The Risk/Reward Of Avidity Biosciences And Its 2 Promising Programs
Avidity Biosciences, Inc.'s innovative AOC platform and promising clinical programs make it a high-risk, high-reward ...
Turn Biotechnologies Acquires ARMMs Vesicular Technology to Increase Access to Tissue Targets for its Epigenetic Reprogramming Therapies
ARMMs brings precision medicine through targeted, non-viral vesicular delivery Synergy of ARMMs and eTurna™ LNP platforms ...
Technology Networks5d
Intercellular mRNA Transfer Reprograms Stem Cells
A new study has found that messenger RNA can travel between different stem cells and reprogram human cells to an earlier ...
Vietnam Investment Review on MSN6d
Everest Medicines Announces FDA Clearance of IND Application for Tumor Associated Antigen Vaccine EVM14
EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical ...